Pulse.

a daily field guide to health research that matters

◆ Console

‹ Tue · 3 Nov 2026
Standard addition

Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials.

Semaglutide helps adults achieve meaningful weight loss when diet and exercise alone haven't worked, though effects vary between individuals.

BACKGROUND, Obesity poses significant challenges for those seeking long-term weight loss through diet and exercise alone. CONCLUSION, Semaglutide was associated with clinically meaningful weight loss during trial treatment periods in adults with overweight or obesity without diabetes, however, low-certainty evidence and substantial between-study heterogeneity warrant cautious interpretation of the magnitude of benefit.

What the study was

Study design
Systematic review and meta-analysis of randomized trials
Population
adults
Sample size
6975
Category
Treatment Innovation
Maturity
Validated
Journal
Journal of diabetes and metabolic disorders

Why it surfaced

Abstract-reviewed systematic review and meta-analysis of randomized trials scored conservatively for treatment innovation; 8/10 reflects the available design, relevance, novelty, and population or unmet-need evidence.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.